Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or Zepbound.
Nurse who tried Mounjaro becomes first confirmed UK death linked to NHS weight loss jabs
Weight
loss
injections can be purchased from any registered pharmacy in the UK but buyers are required to enter information about their health. High demand means the health service has announced a phased rollout of
Mounjaro
after it was approved for ...
Nurse’s death linked to approved weight-loss drug
The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.
Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs
These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates appetite and digestion. The medications control blood sugar and help people eat less,
Weight-loss drug Mounjaro linked to death of Scots nurse
The death of a Scots nurse has been linked to an approved weight loss injection which is available on NHS. Susan McGowan, from North Lanarkshire, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, for about two weeks before her death on 4 September.
Weight loss drugs UK: The different types of weight loss drugs explained as nurse's death linked to Mounjaro
Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to be effective for weight loss. It has been recommended as a weight loss drug for adults, with proposals for the phased launch of it on the NHS being set out by NICE.
Nurse becomes first UK death linked to NHS-approved weight-loss jab Mounjaro
A weight drug recently legalised in the UK contributed to the death of a 58-year-old nurse, according to a new report.
Scottish nurse’s death linked to approved weight-loss drug Mounjaro
Mounjaro and Ozempic are both self-injectable medications designed to regulate blood sugar levels in adults with type 2 diabetes. In the UK, Mounjaro is also approved for weight loss, whereas Ozempic is only authorised for managing type 2 diabetes.
First death connected to weight loss jabs approved by NHS as nurse dies after two doses
Tragedy struck as Susan McGowan, a 58 year old NHS bed manager, died after taking two doses of the weight loss drug Mounjaro, which has been hailed as the "King Kong" of slimming injections. Despite being prescribed to over 250,
tyla
2d
Mounjaro explained as Adam Lambert speaks out on drastic weight loss and why he stopped taking Ozempic
Mounjaro explained as Adam Lambert speaks out on Instagram live about his drastic weight loss and why he stopped taking ...
1d
Are weight loss jabs like Mounjaro and Wegovy still the answer to Britain's obesity crisis?
The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...
2d
on MSN
‘American Idol’s’ Adam Lambert Flaunts 60-Pound Weight Loss
Adam Lambert stepped out in New York City on November 5 and showed off the 60-pound weight loss that he's been working on.
tyla
3d
Adam Lambert reveals drastic weight loss as he shares what happened when he switched from Ozempic to different drug
Queen and American Idol star Adam Lambert revealed he has lost 60lbs and says it happened after switching from Ozempic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Susan McGowan
National Health Service
Feedback